Kirchhof, P.Benussi, S.Kotecha, D.Ahlsson, A.Atar, D.Casadei, B.Castella, M.Diener, H.-C.Heidbuchel, H.Hendriks, J.Hindricks, G.Manolis, A.Oldgren, J.Popescu, B.Schotten, U.Van Putte, B.Vardas, P.Agewall, S.Camm, J.Baron Esquivias, G.et al.2017-06-012017-06-012016European Heart Journal, 2016; 37(38):2893-29620195-668X1522-9645http://hdl.handle.net/2440/105597Abstract not availableen© The European Society of Cardiology 2016. All rights reserved.Guidelines; atrial fibrillation; anticoagulation; vitamin K antagonists; non-vitamin K antagonist oral anticoagulants; left atrial appendage occlusion; rate control; cardioversion; rhythm control; antiarrhythmic drugs; upstream therapy; catheter ablation; AF surgery; valve repair; pulmonary vein isolation; left atrial ablation about this publication2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTSJournal article003007018710.1093/eurheartj/ehw2100003870051000172-s2.0-84994501747353333Hendriks, J. [0000-0003-4326-9256]